Demonstration of inhibition of cyclic AMP accumulation in brain by very low concentrations of lithium in the presence of alpha-adrenoceptor blockade.
In the present paper, we have studied the effect of lithium on cAMP levels induced by isoprenaline and norepinephrine in the presence of alpha- or beta-adrenoceptor antagonists. Our results show that low lithium concentrations, starting at 0.3 x 10(-3) M, have a significant inhibitory effect on cAMP content induced by isoprenaline in brain tissue pretreated with the alpha-adrenoceptor blocker phenoxybenzamine. On the other hand, the inhibitory effect of lithium on cAMP levels induced by norepinephrine when beta-adrenoceptors are blocked with propranolol, is observed at concentrations starting at 2.5 x 10(-3) M. These results show that in the presence of alpha blockade, low lithium concentrations which are within the therapeutic plasma range for treatment of manic patients, are able to act on an adenylate cyclase-cAMP system coupled to beta-adrenoceptors.
Unitat de Farmacologia, Facultat de Medicina, Universitat de Barcelona, Spain.
F
F
Mármol
L
L
Carbonell
M L
ML
Cuffí
J
J
Forn
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D002712:Chlorides / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology*; D018021:Lithium Chloride; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D000317:Adrenergic alpha-Antagonists; D002712:Chlorides; D010643:Phenoxybenzamine; D008094:Lithium; D011433:Propranolol; D000242:Cyclic AMP; D018021:Lithium Chloride; D007545:Isoproterenol; D009638:Norepinephrine